Alterations in Genes Associated with Bioactive Lipid Pathways during Development of Pulmonary Hypertension in Rat SU5416-Hypoxia Model of Severe Pulmonary Arterial Hypertension

Medicine & Life Sciences

• Semaxinib 100%
• Pulmonary Arterial Hypertension 70%
• Pulmonary Hypertension 59%
• Heart Ventricles 47%
• Hypoxia 47%
• Lipids 39%
• Lung 32%
• Genes 24%
• Vascular Remodeling 23%
• Ventricular Remodeling 15%
• Ventricular Pressure 14%
• Heart 8%
• Blood Pressure 8%
• Gene Expression 8%
• Injections 7%
• Patient Rights 7%
• Microvessels 6%
• Isoenzymes 6%
• Cytochrome P-450 Enzyme System 6%
• Vascular Diseases 6%
• Hypertrophy 6%
• Lung Diseases 5%
• Sprague Dawley Rats 5%
• Arterial Pressure 5%
• Air 5%
• Cause of Death 5%
• Histology 5%
• Survival Rate 5%
• Heart Failure 4%
• Therapeutics 1%

Chemical Compounds

• Pressure 34%
• Cytochrome P450 21%